1. Home
  2. DINO vs RGEN Comparison

DINO vs RGEN Comparison

Compare DINO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DINO
  • RGEN
  • Stock Information
  • Founded
  • DINO 1947
  • RGEN 1981
  • Country
  • DINO United States
  • RGEN United States
  • Employees
  • DINO N/A
  • RGEN N/A
  • Industry
  • DINO Oil & Gas Production
  • RGEN Medical/Dental Instruments
  • Sector
  • DINO Energy
  • RGEN Health Care
  • Exchange
  • DINO Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • DINO 8.2B
  • RGEN 7.6B
  • IPO Year
  • DINO N/A
  • RGEN N/A
  • Fundamental
  • Price
  • DINO $33.74
  • RGEN $144.46
  • Analyst Decision
  • DINO Buy
  • RGEN Buy
  • Analyst Count
  • DINO 10
  • RGEN 12
  • Target Price
  • DINO $50.33
  • RGEN $187.44
  • AVG Volume (30 Days)
  • DINO 2.4M
  • RGEN 531.4K
  • Earning Date
  • DINO 02-19-2025
  • RGEN 11-12-2024
  • Dividend Yield
  • DINO 5.92%
  • RGEN N/A
  • EPS Growth
  • DINO N/A
  • RGEN N/A
  • EPS
  • DINO 1.70
  • RGEN N/A
  • Revenue
  • DINO $29,740,252,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • DINO N/A
  • RGEN $2.23
  • Revenue Next Year
  • DINO N/A
  • RGEN $10.07
  • P/E Ratio
  • DINO $19.84
  • RGEN N/A
  • Revenue Growth
  • DINO N/A
  • RGEN N/A
  • 52 Week Low
  • DINO $33.52
  • RGEN $113.50
  • 52 Week High
  • DINO $64.16
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • DINO 19.64
  • RGEN 45.89
  • Support Level
  • DINO $38.30
  • RGEN $143.91
  • Resistance Level
  • DINO $40.17
  • RGEN $161.24
  • Average True Range (ATR)
  • DINO 1.15
  • RGEN 6.16
  • MACD
  • DINO -0.55
  • RGEN -0.96
  • Stochastic Oscillator
  • DINO 2.67
  • RGEN 12.10

About DINO HF Sinclair Corporation

HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: